Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study
Gut and Liver · 15.03.2026 · 20 (2) · 305-314
DOI: 10.5009/gnl250346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gut and Liver, online erschienen am 27.11.2025. Verfasst von Ji Young Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Behcet Syndrome, Tumor Necrosis Factor-alpha, Intestinal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, Wooduk Scholarship Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion Medicine, Ewha Womans University Seoul Hospital, Seoul, Korea.
- Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
- Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- Inflammatory Bowel Disease Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
ORCID-Profile: Ji Young Chang, Jiwoo Kim, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Wooduk Scholarship Foundation
Zitieren
APA
Chang, J. Y., Kim, J., Park, S. J., Park, J. J., Kim, T. I., Cheon, J. H., & Park, J. (2026). Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study. Gut and Liver, 20(2), 305-314. https://doi.org/10.5009/gnl250346
Vancouver
Chang JY, Kim J, Park SJ, Park JJ, Kim TI, Cheon JH, et al. Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study. Gut and Liver. 2026;20(2):305-314. doi:10.5009/gnl250346
BibTeX
@article{Chang2026,
author = {Chang, Ji Young and Kim, Jiwoo and Park, Soo Jung and Park, Jae Jun and Kim, Tae Il and Cheon, Jae Hee and Park, Jihye},
title = {Effectiveness and Tolerability of Anti-Tumor Necrosis Factor Alpha Therapy in Refractory Intestinal Behçet’s Disease: A Large Single-Center Study},
journal = {Gut and Liver},
year = {2026},
volume = {20},
number = {2},
pages = {305--314},
doi = {10.5009/gnl250346}
}
EUVIMED